NZCurrent Trials
  • Home
  • Clinical Trials
  • Sarbecovirus Vaccine Studies Sydney DH

Sarbecovirus Vaccine Study

Darlinghurst Sydney

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming vaccine studies here.

Description

What to expect

Study details

Ages

18 to 55 years of age

Duration

The study duration is up to 14 months, including up to 11 in clinic visits

Compensation

Participants will be compensated up to $1,900

Eligibility Criteria

You may be eligible if you:

  • Are aged 18 to 55 years
  • Are generally healthy
  • Have previously received COVID-19 vaccinations including at least one booster
  • Have received a COVID-19 vaccine at least 6 months go
  • Have not had COVID-19 in the past 6 months

Other eligibility criteria apply.

Locations

Darlinghurst Sydney

Description

Coronaviruses, including those that cause COVID-19, continue to evolve and pose an ongoing global health challenge. While existing vaccines have been highly effective at reducing severe illness and hospitalisation, new variants and related coronaviruses can change over time, which may affect how long protection lasts.

Vaccines work by training the immune system to recognise and respond to viruses before illness occurs. This clinical research study is evaluating an investigational vaccine designed to stimulate a broader immune response, with the aim of helping the body recognise shared features across a range of coronaviruses. By targeting these common features, this approach may support protection not only against current viruses, but also against related coronaviruses that could emerge in the future.

This study is exploring a new vaccine strategy that looks beyond individual variants and focuses on longer-term preparedness. The study will help researchers better understand how the immune system responds to this investigational vaccine and how it may contribute to future vaccine development.

This is an early-phase clinical research study. Participants are not expected to receive a direct health benefit. However, the information collected may help researchers develop future vaccines that could improve global pandemic preparedness.

What to expect

Participants will be randomly assigned to receive either the investigational vaccine or a control vaccine (already approved vaccine). Depending on the study group, you may receive one or two injections during scheduled clinic visits. 

Throughout the study you will attend regular clinic visits for health assessments, which may include physical examinations, blood tests, and general health checks. These visits help the research team monitor your health and collect important study information. 

Your safety and wellbeing will be closely monitored by our professional clinical team for the duration of the study

Why join this clinical research study?

  • Contribute to important medical research that supports future vaccine development
  • Receive study-related health checks at no cost
  • Be support and monitored by a professional clinical research team
  • Be compensated for your time and travel

Your privacy is important and all personal information will be kept strictly confidential. 

Register your interest today.

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming vaccine studies here.

Therapeutic AreasClinical TrialsAboutContactCareersNews
ParticipantsSponsors

Australian locations

Darlinghurst SydneyCanberraSt Leonards SydneySunshine MelbourneTaringa Brisbane

New Zealand locations

AucklandPukekohe AucklandNorth Auckland

2026 © Momentum Clinical Research

Privacy Policy
West Auckland
Waikato
Tauranga
Rotorua
Palmerston North
Kapiti
Wellington
Hutt Valley
Nelson
Christchurch
Dunedin